KUALA LUMPUR: Supermax Corp Bhd
will begin commercialising glove production at its first US manufacturing facility in Texas by January 2025.
The glovemaker, through its wholly-owned subsidiary Maxter Healthcare Inc., will begin testing and commissioning its first production lines in December 2024.
The company anticipates achieving half capacity of Phase 1 operations by next year 2025, producing up to 2.4 billion pieces of gloves per annum.
The remaining of Phase 1 is expected to be completed in the fourth quarter of 2025, adding another 2.4 billion pieces per annum to a total of 4.8 billion gloves per annum for its US production capacity.
“Our US plant incorporates a ‘smart manufacturing’ process, featuring digital process control and fully automated end-to-end manufacturing. This approach reduces our reliance on blue-collar labour and leverages the latest technology, including artificial intelligence, automation, and robotics,” founder and executive chairman Datuk Seri Stanley Thai said in a statement.
Supermax has plans for Phase 2 of its production to be installed within the next two years and will be subjected to its monitoring of the global demand and consumption market.
